CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 70 filers reported holding CARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $50,224 | -59.4% | 10,229 | -11.2% | 0.00% | – |
| Q4 2022 | $123,768 | +23.8% | 11,524 | +7.8% | 0.00% | – |
| Q3 2022 | $100,000 | +5.3% | 10,688 | +2.6% | 0.00% | – |
| Q2 2022 | $95,000 | -48.9% | 10,420 | -32.0% | 0.00% | – |
| Q1 2022 | $186,000 | -17.7% | 15,321 | -17.4% | 0.00% | – |
| Q4 2021 | $226,000 | -16.3% | 18,555 | +6.1% | 0.00% | -100.0% |
| Q3 2021 | $270,000 | -12.9% | 17,480 | -19.4% | 0.00% | 0.0% |
| Q2 2021 | $310,000 | -20.1% | 21,689 | +21.4% | 0.00% | 0.0% |
| Q1 2021 | $388,000 | +52.8% | 17,872 | +6.3% | 0.00% | 0.0% |
| Q4 2020 | $254,000 | +58.8% | 16,809 | +33.4% | 0.00% | 0.0% |
| Q3 2020 | $160,000 | -28.6% | 12,601 | -3.6% | 0.00% | 0.0% |
| Q2 2020 | $224,000 | -10.4% | 13,071 | -15.7% | 0.00% | 0.0% |
| Q4 2019 | $250,000 | -20.1% | 15,497 | -9.4% | 0.00% | -50.0% |
| Q3 2019 | $313,000 | -3.4% | 17,101 | +13.6% | 0.00% | 0.0% |
| Q2 2019 | $324,000 | -2.4% | 15,053 | -11.1% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +52.3% | 16,940 | +0.8% | 0.00% | 0.0% |
| Q4 2018 | $218,000 | -54.5% | 16,802 | -16.0% | 0.00% | -33.3% |
| Q3 2018 | $479,000 | +44.3% | 20,006 | +15.6% | 0.00% | +50.0% |
| Q2 2018 | $332,000 | +45.0% | 17,313 | -6.4% | 0.00% | +100.0% |
| Q1 2018 | $229,000 | -13.3% | 18,491 | -14.1% | 0.00% | -50.0% |
| Q4 2017 | $264,000 | +64.0% | 21,534 | +11.7% | 0.00% | 0.0% |
| Q3 2016 | $161,000 | +46.4% | 19,281 | -15.7% | 0.00% | +100.0% |
| Q2 2016 | $110,000 | -21.4% | 22,880 | +2.0% | 0.00% | -50.0% |
| Q1 2016 | $140,000 | -66.5% | 22,436 | -9.5% | 0.00% | -60.0% |
| Q4 2015 | $418,000 | +29.4% | 24,790 | +9.6% | 0.01% | 0.0% |
| Q3 2015 | $323,000 | +30.8% | 22,615 | +11.2% | 0.01% | +66.7% |
| Q2 2015 | $247,000 | +26.7% | 20,344 | +4.9% | 0.00% | +50.0% |
| Q1 2015 | $195,000 | +20.4% | 19,395 | +19.4% | 0.00% | 0.0% |
| Q4 2014 | $162,000 | – | 16,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $47,864,000 | 31.00% |
| Chescapmanager LLC | 1,484,303 | $25,382,000 | 4.27% |
| Cypress Capital Management LLC (WY) | 179,920 | $3,077,000 | 3.07% |
| DAFNA Capital Management LLC | 371,033 | $6,345,000 | 1.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $10,715,000 | 0.98% |
| Prosight Management, LP | 86,965 | $1,487,000 | 0.64% |
| ETF MANAGERS GROUP, LLC | 901,714 | $15,419,000 | 0.55% |
| Carmignac Gestion | 2,065,153 | $35,314,000 | 0.49% |
| Ikarian Capital, LLC | 273,524 | $4,677,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $39,330,000 | 0.32% |